Retroviral vectors were used to introduce the wild-type p53 gene into human bladder cancer cell lines BIU-87 and EJ, which express endogenous wt-p53 gene and have a mutation in H-ras gene. The expression of the exogenous wt-p53 gene in cells suppresses the growth of the bladder cancer cells in stand
Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism
โ Scribed by Makoto Hori; Keiji Suzuki; Masako U. Udono; Motohiro Yamauchi; Mariko Mine; Masami Watanabe; Shigeo Kondo; Yutaka Hozumi
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 854 KB
- Volume
- 301
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
HCC patients are generally resistant to chemotherapy, Selective expression of cytotoxic gene products in tuwhich, in some cases, may be the result of a loss of function mor cells is one of the goals of gene therapy for treating mutation in the p53 gene. cancer. We are developing such a strategy for
2-Acetylaminofluorene (AAF) is a potent tumor promoter in rat liver carcinogenesis models. In the resistant hepatocyte model, AAF is combined with a growth stimulus for efficient promotion of preneoplastic lesions. The promoting property of AAF in this model is closely associated with mito-inhibitio